StockFame
  • Trending News
  • Markets
  • US Markets
  • Indian Stocks
  • Economics
  • Crypto News
Select Page

FDA Approves First-Ever Gene Therapy to Restore Hearing

by Wallstreet Journal | April 24, 2026 2:06 am | US Markets

Regeneron’s drug restored hearing in 11 of 12 children in a rare, inherited condition that causes deafness.

Recent Posts

  • Aave rallies DeFi partners to contain fallout from $292 million KelpDAO hack
  • Anchorage Digital adds Marinade-powered staking strategies for Solana clients
  • Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
  • FDA Approves First-Ever Gene Therapy to Restore Hearing
  • Intel Sales Rise 7% as AI Agents Drive Growth

About Stockfame

Stockfame is a global media platform delivering bold insights on business, markets, technology, leadership, and entrepreneurship. We bring you research-backed news and sharp analysis to help you stay ahead of the curve.

Quick News Links

  • Crypto News
  • Indian Stocks
  • Latest Posts
  • Market
  • News
  • Trending News
  • US Markets

Contact Us

Reach out to us at:
Phone:  [+91] 9834938257
Email: contact@stockfame.com
For Advertisement, Press Releases, Partnerships or to get backlinks on this website, please e-mail us at contact@stockfame.com

Quick Reads

  • Global market news
  • Crypto Market News
  • Indian Market News
  • Economy News
  • Latest Business News
  • About
  • Terms and Conditions
  • Privacy Policy
  • Website User Agreement
  • Disclaimer
  • Facebook
  • X
  • Instagram
  • RSS
Copyright @StockFame | All Rights Reserved